Unknown

Dataset Information

0

Therapeutic approaches in Congenital Disorders of Glycosylation (CDG) involving N-linked glycosylation: an update.


ABSTRACT: Congenital disorders of glycosylation (CDG) are a group of clinically and genetically heterogeneous metabolic disorders. Over 150 CDG types have been described. Most CDG types are ultrarare disorders. CDG types affecting N-glycosylation are the most common type of CDG with emerging therapeutic possibilities. This review is an update on the available therapies for disorders affecting the N-linked glycosylation pathway. In the first part of the review, we highlight the clinical presentation, general principles of management, and disease-specific therapies for N-linked glycosylation CDG types, organized by organ system. The second part of the review focuses on the therapeutic strategies currently available and under development. We summarize the successful (pre-) clinical application of nutritional therapies, transplantation, activated sugars, gene therapy, and pharmacological chaperones and outline the anticipated expansion of the therapeutic possibilities in CDG. We aim to provide a comprehensive update on the treatable aspects of CDG types involving N-linked glycosylation, with particular emphasis on disease-specific treatment options for the involved organ systems; call for natural history studies; and present current and future therapeutic strategies for CDG.

SUBMITTER: Verheijen J 

PROVIDER: S-EPMC8720509 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC5707694 | biostudies-literature
2008-07-11 | GSE8440 | GEO
| S-EPMC9369176 | biostudies-literature
2008-10-18 | E-GEOD-8440 | biostudies-arrayexpress
| S-EPMC1734666 | biostudies-other
| S-EPMC7408855 | biostudies-literature
| S-EPMC8260486 | biostudies-literature
| S-EPMC6331365 | biostudies-literature
| S-EPMC1763046 | biostudies-other
| S-EPMC3509848 | biostudies-literature